New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Longeveron Inc.
LGVN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

24M

Biotechnology

Next Earning date - 13 May 2025

24M

Biotechnology

Next Earning date - 13 May 2025

1.75USD

Shape0.12 ( 7.36%)
Market Closed (as of Apr 25, 20:00 EDT)
favorite-chart

Relative Strenght

40
favorite-chart

Volume Buzz

-39%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated April 27, 2025
1W 15.13 % 1M 10.76 % 3M 9.37 % 1Y 3.55 %

Key Metrics

Shape
  • Market Cap

    23.58M


  • Shares Outstanding

    13.47M


  • Share in Float

    12.38M


  • Dividende

    0


  • Earning Date

    13 May 2025


  • Price Target

    1.75


  • Average Volume

    252314


  • Beta

    0.375


  • Range

    0.771-6.4


  • Industry

    Biotechnology


  • Website

    https://www.longeveron.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LGVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape292%

2025-Revenue

$1.24

Shape-359%

2025-EPS

$2M

Shape47%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-2.20
vs -1.70

Q2.23

arrow
arrow

N/A

-2.70
vs -2.70

Q3.23

arrow
arrow

N/A

-2.80
vs -2.50

Q4.23

arrow
arrow

N/A

-2.50
vs -2.10

Q1.24

arrow
arrow

N/A

-1.61
vs -2.20

Q2.24

arrow
arrow

N/A

-1.83
vs -2.70

Q3.24

arrow
arrow

N/A

-0.34
vs -2.80

Q4.24

arrow
arrow

N/A

-2.50
vs -2.50

Q1.25

arrow
arrow

N/A

-0.33
vs -1.61

Q2.25

arrow
arrow

N/A

-0.30
vs -1.83

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-25%

279K  vs 370K

Q2.23

arrow
arrow

-53%

217K  vs 466K

Q3.23

arrow
arrow

-43%

150K  vs 265K

Q4.23

arrow
arrow

-48%

63K  vs 121K

Q1.24

arrow
arrow

+96%

548K  vs 279K

Q2.24

arrow
arrow

+116%

468K  vs 217K

Q3.24

arrow
arrow

+415%

773K  vs 150K

Q4.24

arrow
arrow

+857%

603K  vs 63K

Q1.25

arrow
arrow

+10%

600.3K  vs 548K

Q2.25

arrow
arrow

+31%

611K  vs 468K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-28%

-0.28
vs -0.18

Q2.23

arrow
arrow

-50%

-0.50
vs -0.28

Q3.23

arrow
arrow

-89%

-0.89
vs -0.50

Q4.23

arrow
arrow

-88%

-0.88
vs -0.89

Q1.24

arrow
arrow

-133%

-1.33
vs -0.88

Q2.24

arrow
arrow

-23%

-0.23
vs -1.33

Q3.24

arrow
arrow

-17%

-0.17
vs -0.23

Q4.24

arrow
arrow

-19%

-0.19
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

14

14
vs 16

-12%

Q2.23

arrow
arrow

20

20
vs 14

43%

Q3.23

arrow
arrow

18

18
vs 20

-10%

Q4.23

arrow
arrow

20

20
vs 18

11%

Q1.24

arrow
arrow

11

11
vs 20

-45%

Q2.24

arrow
arrow

18

18
vs 11

64%

Q3.24

arrow
arrow

16

16
vs 18

-11%

Q4.24

arrow
arrow

21

21
vs 16

31%

Earnings Growth

Latest News